Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Vis graf over relationer


Haemato-oncologist. Responsible for treatment of malignant lymphoma and for experimental/phase I treatment of haematological malignancies at Rigshospitalet. Head of service for Hodgkin lymphoma, Mantle cell lymphoma and Castleman’s disease.

Primære forskningsområder

Hodgkin lymphoma; Mantle cell lymphoma; PET/CT in lymphoma; PET-response adapted lymphoma treatment; Phase 1 haematology studies;

Aktuel forskning

Chairman of the  EORTC lymphoma group since 2013. Co-author of the international response criteria and guidelines for the use of imaging in lymphoma. Co-author of the European society of Medical Oncology (ESMO) guidelines for Hodgkin lymphoma and ’ultra high-risk’ lymphomas.

Faculty member for the EHA Clinical Research Training in Haematology programme

Member of the scientific committee for the European Haematology Association

National principal investigator or sub-investigator for >25 solid tumour and haematology phase I trials

National principal investigator for three mantle cell lymphoma trials (one ongoing and two planned) and three Hodgkin lymphoma trials.

Site principal investigator or sub-investigator for >20 lymphoma and myeloma phase II and phase III trials

Mulige interessekonflikter


ID: 27735